New injection aims to fight Cancer-Related wasting
NCT ID NCT07584057
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new drug called INB301 in people with cancer who are losing weight and muscle (cancer cachexia). The goal is to see if it is safe and can help patients gain or maintain weight. About 146 adults with solid tumors like lung, pancreatic, or colorectal cancer will receive injections over several weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- INB301 injection
- What this could lead to
- If it works, this could point toward a treatment that helps cancer patients maintain weight and feel stronger.
- What could go wrong
- This is an early-phase trial with only 146 participants, so results may not apply broadly. Side effects and lack of benefit are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER CACHEXIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
52 Fucheng Road, Haidian District
Beijing, Beijing Municipality, 100142, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ear acupressure: a new weapon against chemotherapy side effects?
- Can a Custom-Made immune cell vaccine turn the tide against solid tumors?
- Can a new tracer light up tumors better than standard PET scans?
- Can a new injection stop the wasting of cancer cachexia?
- Personalized weight loss coaching could help cancer survivors shed pounds
- Could probiotics help breast cancer patients keep their strength?